Patent Term Extension Application for POMBILITI (cipaglucosidase alfa-atga), Patent No. 10,208,299 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2024-E-0847

Patent Term Extension Application for POMBILITI (cipaglucosidase alfa-atga), Patent No. 10,208,299

Documents

Comments

Description

OPEN

Comment Period OpensFeb 16, 2024

Comment Period ClosesAug 16, 2025

Type	Title	Posted	Comments	Status
Other	Letter to U. S. Patent and Trademark Office	Apr 20, 2026	--

CDER

Patent Term Extension Application

Servilla Whitney LLC

Amicus Therapeutics, Inc

POMBILITI (cipaglucosidase alfa-atga)

Patent No. 10,208,299

OPEN